Ganciclovir

Back to search

Molecule Structure

Scientific Name

Ganciclovir

Description of the Drug

Ganciclovir is a DNA polymerase inhibitor used to treat cytomegalovirus and herpetic keratitis of the eye.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01004

Brand Name(s)

Cymevene, Cytovene, Ganciclovir, Ganzyk-rtu, Virgan, Vitrasert, Zirgan

Company Owner(s)

Roche Palo Alto Llc, Fresenius Kabi Usa Llc, Custopharm Inc, Steriscience Pte Ltd, Pharmascience Inc, Par Sterile Products Llc, American Regent Inc, Cheplapharm Arzneimittel Gmbh, Bausch And Lomb Inc, Exela Pharma Sciences Llc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Human herpesvirus 1 DNA polymerase SINGLE PROTEIN INHIBITOR CHEMBL1872

Unichem Links

SureChEMBL SCHEMBL3033
PharmGKB PA449733
Human Metabolome Database HMDB0015139
DrugBank DB01004
PubChem: Thomson Pharma 16217245 14798783 14749970
PubChem 135398740
Mcule MCULE-9512761592
NMRShiftDB 60021391
LINCS LSM-5382
Nikkaji J22.096E
PDBe GA2
BindingDB 85707 50237614
EPA CompTox Dashboard DTXSID8041032
DrugCentral 1277
Brenda 2899 166475 209607
ChemicalBook CB6203364
rxnorm ZIRGAN GANCICLOVIR SODIUM GANCICLOVIR CYTOVENE
PubChem: Drugs of the Future 12013652
ChEBI 465284
ZINC ZINC000000001505